Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors
| Registry | NCT03154801, acronym NEUROSEX |
|---|---|
| Status | Unknown |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, treatment |
| Enrollment | 54 (Estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris (Other) |
| Conditions | Low Grade Glioma of Brain, Multiple Sclerosis, Sexual Dysfunctions |
| Interventions | Paramedical care (Other) |
| Dates | start 2017-07-26, primary completion 2022-01-26, completion 2022-07-26 (estimated), first posted 2017-05-16, last updated 2022-02-18 |
| Locations | 1 site in France |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Low Grade Glioma of Brain All trials for Multiple Sclerosis All trials of Paramedical care
This study aim to ensure that the implementation of a paramedical screening program and counseling in sexual health of patients with neurological pathologies (low-grade gliomas and Multiple Sclerosis) improves their sexual health.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Paramedical care | Experimental | Other: Paramedical care | paramedical early detection of sexual dysfunction and sexual health counseling |
Sex: All, ages: 18 Years to any
Inclusion Criteria: 1. Any major patient, followed in the GHPSCF (Groupe Hospitalier Pitié-Salpêtrière Charles Foix) neurology department 2 for a diagnosis of low grade glioma or anaplastic glioma with loss 1p / 19q sub-reserve histo-molecular confirmation after national reading (POLA) and presenting: * An MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire) questionnaire with at least one of the items rated "4" or "5" and * A HAD (Hospital Anxiety and Depression) questionnaire (depression component) with a score ≤ 11 2. Any major patient with MS(Multiple Sclerosis), followed in the GHPSCF Department of Neurology: * With an EDSS (Expanded Disability Status Scale) greater than or equal to 1 and * An MSISQ15 questionnaire with at least one of the items rated "4" or "5". * A HAD questionnaire (depression component) with a score ≤ 11 3. Signature of informed consent 4. Patient affiliated to a social security system Exclusion Criteria: 1. Minor patients 2. Pregnant women 3. Patients who do not understand and / or speak French and / or are unable to sign consent 4. Patients with neurological impairment 5. Patients with chronic sexual disorders who have already received treatment. 6. Patients with a HAD score (depression component) greater than 11 7. Patients with MS who had a corticosteroid-treated outbreak in the last two months. 8. Patients with low-grade glioma with clinical and / or radiological scalability during the last three months 9. Any patient whose alteration of the general state would not allow to follow the program. 10. Patients under legal protection For patient's partners: Inclusion criteria: 1. Any patient partner, whose patient has wished to participate and who has accepted. 2. Signing of informed consent Non-Inclusion Criteria: 1. Minor partners 2. Pregnant women 3. Any person who does not understand and / or speak French and / or is unable to sign the consent 4. Partners under legal protection
| Facility | City | Country | Status |
|---|---|---|---|
| Groupe Hospitalier Pitie Salpetriere | Paris | France |